We present the new webinar of Agena, titled: Recent Developments in PGx: Predictive Biomarker Identification & Relevance.
Newly identified biomarkers, and evidence to support their potential pharmacogenomic relevance, can help address challenges involved with optimizing personalized drug therapy.
 |
Webinar |
 |
Register |
 |
Thursday, May 26 |
In this webinar, Dr. David Kisor from Manchester University will present the latest evidence supporting newly identified (predictive) biomarkers for pharmacogenomics as well as evaluating the relevance of certain existing biomarkers. He will introduce a new resource that will be available for comparing and contrasting Clinical Pharmacogenetic Implementation Consortium and U.S. Food and Drug Administration PGx data.
Leave a reply